Cipla and DNDi announce the forthcoming launch of Artesunate + Mefloquine fixed-dose combination for P. falciparum malaria

Cipla and DNDi announce the forthcoming launch of Artesunate + Mefloquine fixed-dose combination for P. falciparum malaria

Mumbai – Geneva, 24th April 2012: On the occasion of World Malaria Day, Cipla, one of the world’s leading generic...